TITLE

Antworten zu den Fragen zumThema « Fehlender Blutdruckanstieg bzw. Blutdruckabfall während der Ergometrie » aus PRAXIS Nr. 13

PUB. DATE
July 2011
SOURCE
Praxis (16618157);7/6/2011, Vol. 100 Issue 14, p874
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
62566686

 

Related Articles

  • Low prevalence of cardiac troponin T mutations in a Greek hypertrophic cardiomyopathy cohort. Miliou, A.; Anastasakis, A.; D'Cruz, L. G.; Theopistou, A.; Rigopoulos, A.; Rizos, I.; Stamatelopoulos, S.; Toutouzas, P.; Stefanadis, C. // Heart;Jul2005, Vol. 91 Issue 7, p966 

    The article discusses low prevalence of cardiac troponin I mutations in a Greek hypertrophic cardiomyopathy cohort. Since the initial description of hypertrophic cardiomyopathy (HCM), sudden cardiac death (SCD) occurring in young and usually asymptomatic patients has received substantial...

  • Systolic Heart Failure in a Patient With Hypertrophic Obstructive Cardiomyopathy. Whitten, Shannon Etheridge // Critical Care Nurse;Oct2008, Vol. 28 Issue 5, p44 

    The article offers information on hypertrophic obstructive cardiomyopathy, a genetically transmitted disease. Complications of the disease include heart failure, atrial and ventricular arrhythmia and sudden cardiac death. Options for patients who do not respond to medication like percutaneous...

  • Insights and challenges in hypertrophic cardiomyopathy, 2012. Sen-Chowdhry, Srijita; Tomé Esteban, María Teresa; McKenna, William J. // Herzschrittmachertherapie und Elektrophysiologie;Sep2012, Vol. 23 Issue 3, p174 

    We present a contemporary overview of hypertrophic cardiomyopathy (HCM), incorporating recent thinking on disease mechanisms and advances in therapy. Clinical, pathological, genetic, and mechanistic definitions of HCM are discussed. The genetic profile of HCM in both adults and children is...

  • High prevalence of Arginine to Glutamine Substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians. Selvi Rani, Deepa; Nallari, Pratibha; Priyamvada, Singh; Narasimhan, Calambur; Singh, Lalji; Thangaraj, Thangaraj // BMC Medical Genetics;2012, Vol. 13 Issue 1, p69 

    Background: Troponin I (TNNI3) is the inhibitory subunit of the thin filament regulatory complex Troponin, which confers calcium-sensitivity to striated muscle actomyosin ATPase activity. Mutations (2-7%) in this gene had been reported in hypertrophic cardiomyopathy patients (HCM). However, the...

  • Novel frameshift mutation in Troponin C (TNNC1) associated with hypertrophic cardiomyopathy and sudden death. Chung, Wendy K.; Kitner, Carrie; Maron, Barry J. // Cardiology in the Young;Jun2011, Vol. 21 Issue 3, p345 

    PurposeHypertrophic cardiomyopathy is the most common cause of sudden death in young people, including trained athletes, and is caused by mutations in genes encoding proteins of the cardiac sarcomere. Mutations in the Troponin C gene (TNNC1) are a rare genetic cause of hypertrophic...

  • Impairment of cardiopulmonary receptor sensitivity in the early phase of heart failure. Modesti P A; Polidori G; Bertolozzi I; Vanni S; Cecioni I // Heart;Jan2004, Vol. 90 Issue 1, p30 

    OBJECTIVES: To characterise the efficiency of the cardiopulmonary baroreflex system in the early phase of heart failure and its relation to limitation of physical activity. DESIGN: Forearm blood flow (venous occlusion plethysmography), vascular resistance, and central venous pressure (CVP),...

  • Diastolic Mitral Regurgitation in Patients With Hypertrophic Cardiomyopathy. Jamal, Nasiruddin; Raizner, Albert E.; Ishimori, Tetsuo; Chahine, Robert A. // Angiology;Oct1978, Vol. 29 Issue 10, p773 

    An analysis of the left ventricular angiograms of 31 patients with hypertrophic cardiomyopathy revealed diastolic mitral regurgitation in 4. a prevalence of 12.9%. The clinical, echocardiographic, angiographic, and hemodynamic data of these patients were reviewed. Diastolic mitral regurgitation...

  • Hypertrophic cardiomyopathy and acute myocardial necrosis with normal coronary arteries. Esteban, M. T. Tome; Ashworth, M. // Heart;Oct2008, Vol. 94 Issue 10, p1357 

    The article presents a case study of a 15-year-old male diagnosed with hypertrophic cardiomyopathy at the age of 5. It states that he attended his local hospital where he deteriorated with severe pulmonary oedema and profound hypotension. It states that this is a rare example of widespread...

  • Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy. van der Merwe, Lize; Cloete, Ruben; Revera, Miriam; Heradien, Marshall; Goosen, Althea; Corfield, Valerie A.; Brink, Paul A.; Moolman-Smook, Johanna C. // Human Genetics;Aug2008, Vol. 124 Issue 1, p57 

    Hypertrophic cardiomyopathy, a common, inherited cardiac muscle disease, is primarily caused by mutations in sarcomeric protein-encoding genes and is characterized by overgrowth of ventricular muscle that is highly variable in extent and location. This variability has been partially attributed...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics